PT Hetzer Medical Indonesia Tbk(ID:MEDS)
Rp58.000.00 (0.00%)
ID:MEDS
PT Hetzer Medical Indonesia Tbk financials statements
Rp58.00
At close:0.00 (0.00%)
PT Hetzer Medical Indonesia Tbk (MEDS) Ratios
PT Hetzer Medical Indonesia Tbk Ratios
ID:MEDS's free cash flow for Q3 2026 was Rp703.50M. For the 2026 fiscal year, ID:MEDS's free cash flow was decreased by Rp-387.53M and operating cash flow was Rp1.09B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.17 | 2.88 | 3.72 | 9.03 | 1.91 |
| Quick Ratio | 0.18 | 0.91 | 1.58 | 4.18 | 0.74 |
| Cash Ratio | 0.06 | 0.04 | 0.11 | 1.29 | 0.18 |
| Solvency Ratio | -0.30 | -0.47 | 0.05 | 0.26 | 1.62 |
| Operating Cash Flow Ratio | -0.12 | 0.39 | 0.50 | -3.14 | 1.73 |
| Short-Term Operating Cash Flow Coverage | -0.20 | 0.85 | 1.18 | -5.53 | 6.65 |
| Net Current Asset Value | Rp 1.02B | Rp 7.76B | Rp 11.55B | Rp 25.25B | Rp -2.62B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.08 | 0.10 | 0.12 | 0.23 |
| Debt-to-Equity Ratio | 0.17 | 0.09 | 0.12 | 0.15 | 0.35 |
| Debt-to-Capital Ratio | 0.14 | 0.08 | 0.11 | 0.13 | 0.26 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.04 | 0.07 | 0.10 | 0.22 |
| Financial Leverage Ratio | 1.28 | 1.15 | 1.18 | 1.18 | 1.54 |
| Debt Service Coverage Ratio | -0.47 | -1.14 | 0.47 | 2.30 | 12.93 |
| Interest Coverage Ratio | -12.25 | -17.78 | -3.77 | 6.04 | 188.96 |
| Debt to Market Cap | 0.07 | 0.07 | 0.07 | 0.05 | 0.04 |
| Interest Debt Per Share | 5.55 | 3.63 | 5.53 | 7.86 | 7.34 |
| Net Debt to EBITDA | -1.80 | -1.50 | 4.72 | 0.62 | 0.27 |
| Profitability Margins | |||||
| Gross Profit Margin | -21.13% | -21.78% | 36.92% | 49.11% | 70.72% |
| EBIT Margin | -124.33% | -121.91% | -11.46% | 12.07% | 45.27% |
| EBITDA Margin | -60.36% | -51.61% | 6.82% | 19.93% | 47.55% |
| Operating Profit Margin | -124.33% | -134.17% | -11.02% | 12.16% | 44.98% |
| Pretax Profit Margin | -129.25% | -129.46% | -15.79% | 1.58% | 45.03% |
| Net Profit Margin | -125.90% | -133.52% | -15.71% | 0.63% | 35.14% |
| Continuous Operations Profit Margin | -125.90% | -133.52% | -15.71% | 0.63% | 35.14% |
| Net Income Per EBT | 97.41% | 103.14% | 99.53% | 39.75% | 78.03% |
| EBT Per EBIT | 103.96% | 96.49% | 143.28% | 13.00% | 100.10% |
| Return on Assets (ROA) | -13.51% | -13.07% | -4.63% | 0.29% | 53.28% |
| Return on Equity (ROE) | -17.28% | -15.07% | -5.48% | 0.34% | 82.03% |
| Return on Capital Employed (ROCE) | -16.68% | -14.39% | -3.54% | 5.98% | 80.81% |
| Return on Invested Capital (ROIC) | -14.16% | -13.78% | -3.39% | 2.30% | 60.17% |
| Return on Tangible Assets | -13.51% | -13.07% | -4.54% | 0.29% | 53.28% |
| Earnings Yield | -7.52% | -10.92% | -3.36% | 0.13% | 10.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.18 | 1.35 | 4.19 | 25.14 | 23.76 |
| Payables Turnover | 8.79 | 9.29 | 16.38 | 11.80 | 9.13 |
| Inventory Turnover | 0.66 | 0.69 | 1.06 | 0.96 | 2.43 |
| Fixed Asset Turnover | 0.15 | 0.14 | 0.44 | 0.87 | 2.16 |
| Asset Turnover | 0.11 | 0.10 | 0.29 | 0.47 | 1.52 |
| Working Capital Turnover Ratio | 1.03 | 0.46 | 0.90 | 1.87 | 13.96 |
| Cash Conversion Cycle | 585.62 | 758.59 | 408.88 | 365.23 | 125.81 |
| Days of Sales Outstanding | 70.52 | 270.00 | 87.06 | 14.52 | 15.36 |
| Days of Inventory Outstanding | 556.63 | 527.87 | 344.11 | 381.63 | 150.44 |
| Days of Payables Outstanding | 41.53 | 39.28 | 22.29 | 30.92 | 39.99 |
| Operating Cycle | 627.15 | 797.87 | 431.17 | 396.15 | 165.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.94 | 1.43 | 2.02 | -9.48 | 8.63 |
| Free Cash Flow Per Share | -1.75 | 1.25 | -1.88 | -22.57 | -8.66 |
| Dividend Paid and CapEx Coverage Ratio | -1.17 | 8.08 | 0.52 | -0.72 | 0.39 |
| Capital Expenditure Coverage Ratio | -1.17 | 8.08 | 0.52 | -0.72 | 0.50 |
| Operating Cash Flow Coverage Ratio | -0.18 | 0.43 | 0.40 | -1.30 | 1.19 |
| Operating Cash Flow to Sales Ratio | -0.22 | 0.35 | 0.14 | -0.35 | 0.18 |
| Free Cash Flow Yield | -2.46% | 2.50% | -2.76% | -16.84% | -5.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.30 | -9.16 | -29.69 | 788.24 | 9.86 |
| Price-to-Sales (P/S) Ratio | 16.73 | 12.22 | 4.68 | 4.88 | 3.46 |
| Price-to-Book (P/B) Ratio | 2.30 | 1.38 | 1.63 | 2.68 | 8.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -40.62 | 39.98 | -36.19 | -5.94 | -19.41 |
| Price-to-Operating Cash Flow Ratio | -75.21 | 35.03 | 33.71 | -14.13 | 19.47 |
| Price-to-Earnings Growth (PEG) Ratio | 6.05 | -0.07 | 0.02 | -7.96 | -0.33 |
| Enterprise Value Multiple | -29.53 | -25.19 | 73.32 | 25.08 | 7.56 |
| Enterprise Value | 118.16B | 83.09B | 113.56B | 188.69B | 272.39B |
| EV to EBITDA | -29.53 | -25.19 | 73.32 | 25.08 | 7.56 |
| EV to Sales | 17.82 | 13.00 | 5.00 | 5.00 | 3.59 |
| EV to Free Cash Flow | -43.26 | 42.52 | -38.68 | -6.09 | -20.14 |
| EV to Operating Cash Flow | -80.10 | 37.26 | 36.02 | -14.49 | 20.20 |
| Tangible Book Value Per Share | 30.91 | 36.23 | 41.70 | 50.09 | 20.78 |
| Shareholders’ Equity Per Share | 30.91 | 36.23 | 41.70 | 50.09 | 20.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | -0.03 | 0.00 | 0.60 | 0.22 |
| Revenue Per Share | 4.24 | 4.09 | 14.54 | 27.48 | 48.51 |
| Net Income Per Share | -5.34 | -5.46 | -2.29 | 0.17 | 17.04 |
| Tax Burden | 0.97 | 1.03 | 1.00 | 0.40 | 0.78 |
| Interest Burden | 1.04 | 1.06 | 1.38 | 0.13 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.90 | 1.12 | 0.58 | 0.44 | 0.26 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.18 | -0.26 | -0.88 | -54.94 | 0.51 |
Currency in IDR
